Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » ITEM 9.01. Financial Statements and Exhibits

This excerpt taken from the EYE 8-K filed Feb 20, 2009.

ITEM 9.01.  Financial Statements and Exhibits

 

(d)  Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release, dated February 20, 2009, of Advanced Medical Optics, Inc.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Advanced Medical Optics, Inc.

 

 

 

 

 

 

 

By:

/s/ Aimee S. Weisner

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

Date: February 20, 2009

 

3


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release, dated February 20, 2009, issued by Advanced Medical Optics, Inc.

 

4

This excerpt taken from the EYE 8-K filed Feb 17, 2009.

ITEM 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit No.

 

Description

 

 

 

2.1

 

Amendment No. 1 to Merger Agreement, dated as of February 17, 2009, by and among the Company, Parent and Purchaser

99.1

 

Memorandum of Understanding, dated as of February 14, 2009, in relation to In re Advanced Medical Optics, Inc. Shareholder Litigation, Case No. 30-2009-00236910.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Advanced Medical Optics, Inc.

 

 

 

 

 

 

 

By:

/s/ Aimee S. Weisner

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

 

 

 

 

Date: February 17, 2009

 

 

 

3


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

2.1

 

Amendment No. 1 to Merger Agreement, dated as of February 17, 2009, by and among the Company, Parent and Purchaser

99.1

 

Memorandum of Understanding, dated as of February 14, 2009, in relation to In re Advanced Medical Optics, Inc. Shareholder Litigation, Case No. 30-2009-00236910.

 

4

This excerpt taken from the EYE 8-K filed Jan 27, 2009.

ITEM 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated January 27, 2009 of Advanced Medical Optics, Inc.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ADVANCED MEDICAL OPTICS, INC.

 

 

 

 

 

 

 

By:

/s/ AIMEE S. WEISNER

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

Date: January 27, 2009

 

3


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated January 27, 2009 of Advanced Medical Optics, Inc.

 

4

This excerpt taken from the EYE 8-K filed Apr 3, 2007.

Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of Business Acquired. Financial statements of the business acquired will be filed by amendment to this Current Report no later than 71 days following the date that this Report is required to be filed.

(b) Pro Forma Financial Information. Pro forma financial information will be filed by amendment to this Current Report no later than 71 days following the date that this Report is required to be filed.

 

Exhibits.    
10.1   Indenture, dated as of April 2, 2007, between Advanced Medical Optics, Inc., the guarantors named therein and Wilmington Trust Company, as Trustee.
10.2   Supplemental Indenture, dated as of April 2, 2007, between Advanced Medical Optics, Inc., the guarantors named therein, IntraLase Corp., and Wilmington Trust Company, as Trustee.
10.3   Registration Rights Agreement, dated as of April 2, 2007, by and among Advanced Medical Optics, Inc., the guarantors named therein, UBS Securities LLC, Goldman Sachs & Co. and Banc of America Securities.
10.4   Credit Agreement, dated April 2, 2007, by and among Advanced Medical Optics, Inc., the guarantors party thereto, UBS Securities LLC, as syndication agent, Goldman Sachs Credit Partners L.P., as documentation agent, Bank of America N.A., as administrative agent, swing line lender and L/C issuer, and the lenders party thereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ADVANCED MEDICAL OPTICS, INC.
  (Registrant)
  By:  

/s/ AIMEE S. WEISNER

Date: April 2, 2007     Aimee S. Weisner
    Executive Vice President,
    Administration, General Counsel and Secretary

EXHIBIT INDEX

 

Exhibit No.    
10.1   Indenture, dated as of April 2, 2007, between Advanced Medical Optics, Inc., the guarantors named therein and Wilmington Trust Company, as Trustee.
10.2   Supplemental Indenture, dated as of April 2, 2007, between Advanced Medical Optics, Inc., the guarantors named therein, IntraLase Corp., and Wilmington Trust Company, as Trustee.
10.3   Registration Rights Agreement, dated as of April 2, 2007, by and among Advanced Medical Optics, Inc., the guarantors named therein, UBS Securities LLC, Goldman Sachs & Co. and Banc of America Securities.
10.4   Credit Agreement, dated April 2, 2007, by and among Advanced Medical Optics, Inc., the guarantors party thereto, UBS Securities LLC, as syndication agent, Goldman Sachs Credit Partners L.P., as documentation agent, Bank of America N.A., as administrative agent, swing line lender and L/C issuer, and the lenders party thereto.
This excerpt taken from the EYE 8-K filed Feb 13, 2007.

Item 9.01               Financial Statements and Exhibits

99.1         Press Release, dated February 13, 2007, of Advanced Medical Optics, Inc.

 

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ADVANCED MEDICAL OPTICS, INC.

 

 

(Registrant)

 

 

 

 

 

 

 

Date: February 13, 2007

By:

/s/ RICHARD A. MEIER

 

 

 

Richard A. Meier

 

 

Chief Operating Officer and

 

 

Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

Exhibit

 

 

No.

 

 

 

 

 

99.1

 

Press release, dated February 13, 2007, issued by Advanced Medical Optics, Inc.

 

4


This excerpt taken from the EYE 8-K filed Oct 26, 2006.

Item 9.01               Financial Statements and Exhibits

99.1         Press Release, dated October 26, 2006, of Advanced Medical Optics, Inc.

 

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ADVANCED MEDICAL OPTICS, INC.

 

 

(Registrant)

 

 

 

 

 

Date: October 26, 2006

 

By:

 

/s/ RICHARD A. MEIER

 

 

 

 

Richard A. Meier,

 

 

 

 

Executive Vice President, President,

 

 

 

 

Eye Care Business and Operations, and

 

 

 

 

Chief Financial Officer

 

3



 

EXHIBIT INDEX

Exhibit

 

 

No.

 

 

 

 

 

99.1

 

Press release, dated October 26, 2006, issued by Advanced Medical Optics, Inc.

 

4


This excerpt taken from the EYE 8-K filed Aug 1, 2006.

Item 9.01               Financial Statements and Exhibits

99.1         Press Release, dated August 1, 2006, of Advanced Medical Optics, Inc.

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ADVANCED MEDICAL OPTICS, INC.

 

(Registrant)

 

 

 

 

Date: August 1, 2006

By:

/s/ RICHARD A. MEIER

 

 

Richard A. Meier

 

 

Executive Vice President, Operations,
President, Eye Care Business, and
Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

Exhibit
No.

 

 

 

 

 

99.1

 

Press release, dated August 1, 2006, issued by Advanced Medical Optics, Inc.

 

4


This excerpt taken from the EYE 8-K filed Jul 12, 2006.

Item 9.01               Financial Statements and Exhibits

99.1         Press Release, dated July 10, 2006, of Advanced Medical Optics, Inc.

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ADVANCED MEDICAL OPTICS, INC.

 

 

(Registrant)

Date: July 10, 2006

 

By:

 

       /S/ AIMEE S. WEISNER

 

 

 

 

 

Aimee S. Weisner, Corporate Vice

 

 

 

 

President, General Counsel and

 

 

 

 

Secretary

3



 

EXHIBIT INDEX

Exhibit
No.

 

 

 

 

 

99.1

 

Press release, dated July 10, 2006, issued by Advanced Medical Optics, Inc.

 

4


EXCERPTS ON THIS PAGE:

8-K
Feb 20, 2009
8-K
Feb 17, 2009
8-K
Jan 27, 2009
8-K
Apr 3, 2007
8-K
Feb 13, 2007
8-K
Oct 26, 2006
8-K
Aug 1, 2006
8-K
Jul 12, 2006

RELATED TOPICS for EYE:

"ITEM 9.01. Financial Statements and Exhibits" elsewhere:

Boston Scientific (BSX)
ABIOMED (ABMD)
Antares Pharma (AIS)
MGC DIAGNOSTICS Corp (ANGN)
AngioDynamics (ANGO)
Alphatec Holdings (ATEC)
AtriCure (ATRC)
BARD C R INC (BCR)
BECTON DICKINSON & CO (BDX)
BioLase Technology (BLTI)
CAS Medical Systems (CASM)
Cantel Medical (CMN)
Cooper Companies (COO)
Conceptus (CPTS)
Haemonetics (HAE)
Home Diagnostics (HDIX)
Integra LifeSciences Holdings (IART)
ICU Medical (ICUI)
Kensey Nash (KNSY)
LeMaitre Vascular (LMAT)
Mesa Laboratories (MLAB)
Merit Medical Systems (MMSI)
Memry (MRY)
NuVasive (NUVA)
Osteotech (OSTE)
OraSure Technologies (OSUR)
Rochester Medical (ROCM)
Retractable Technologies (RVP)
SenoRx (SENO)
SonoSite (SONO)
STAAR Surgical Company (STAA)
Stryker (SYK)
Teleflex (TFX)
Utah Medical Products (UTMD)
Vascular Solutions (VASC)
Orthovita (VITA)
West Pharmaceutical Services (WST)
Young Innovations (YDNT)
Baxter International (BAX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki